Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst NADPH oxidase. 2004

Shohko Tsunawaki, and Lucia S Yoshida, and Satoshi Nishida, and Toshihiro Kobayashi, and Takashi Shimoyama
Department of Infectious Diseases, National Research Institute for Child Health and Development, Setagaya, Tokyo 154-8567, Japan. tsunawaki@nch.go.jp

Reactive oxygen species are a critical weapon in the killing of Aspergillus fumigatus by polymorphonuclear leukocytes (PMN), as demonstrated by severe aspergillosis in chronic granulomatous disease. In the present study, A. fumigatus-produced mycotoxins (fumagillin, gliotoxin [GT], and helvolic acid) are examined for their effects on the NADPH oxidase activity in human PMN. Of these mycotoxins, only GT significantly and stoichiometrically inhibits phorbol myristate acetate (PMA)-stimulated O2- generation, while the other two toxins are ineffective. The inhibition is dependent on the disulfide bridge of GT, which interferes with oxidase activation but not catalysis of the activated oxidase. Specifically, GT inhibits PMA-stimulated events: p47phox phosphorylation, its incorporation into the cytoskeleton, and the membrane translocation of p67phox, p47phox, and p40phox, which are crucial steps in the assembly of the active NADPH oxidase. Thus, damage to p47phox phosphorylation is likely a key to inhibiting NADPH oxidase activation. GT does not inhibit the membrane translocation of Rac2. The inhibition of p47phox phosphorylation is due to the defective membrane translocation of protein kinase C (PKC) betaII rather than an effect of GT on PKC betaII activity, suggesting a failure of PKC betaII to associate with the substrate, p47phox, on the membrane. These results suggest that A. fumigatus may confront PMN by inhibiting the assembly of the NADPH oxidase with its hyphal product, GT.

UI MeSH Term Description Entries
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D003510 Cyclohexanes Six-carbon alicyclic hydrocarbons.
D003573 Cytochrome b Group Cytochromes (electron-transporting proteins) with protoheme (HEME B) as the prosthetic group. Cytochromes Type b,Cytochromes, Heme b,Group, Cytochrome b,Heme b Cytochromes,Type b, Cytochromes,b Cytochromes, Heme,b Group, Cytochrome
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005231 Fatty Acids, Unsaturated FATTY ACIDS in which the carbon chain contains one or more double or triple carbon-carbon bonds. Fatty Acids, Polyunsaturated,Polyunsaturated Fatty Acid,Unsaturated Fatty Acid,Polyunsaturated Fatty Acids,Acid, Polyunsaturated Fatty,Acid, Unsaturated Fatty,Acids, Polyunsaturated Fatty,Acids, Unsaturated Fatty,Fatty Acid, Polyunsaturated,Fatty Acid, Unsaturated,Unsaturated Fatty Acids
D005672 Fusidic Acid An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed). It acts by inhibiting translocation during protein synthesis. Fucithalmic,Fusidate Sodium,Fusidic Acid, Sodium Salt,Fusidin,Silver Fusidate,Sodium Fusidate,Stanicide,Acid, Fusidic,Fusidate, Silver,Fusidate, Sodium,Sodium, Fusidate
D005912 Gliotoxin A fungal toxin produced by various species of Trichoderma, Gladiocladium fimbriatum, Aspergillus fumigatus, and Penicillium. It is used as an immunosuppressive agent. Aspergillin,Gliotoxins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Shohko Tsunawaki, and Lucia S Yoshida, and Satoshi Nishida, and Toshihiro Kobayashi, and Takashi Shimoyama
December 1995, Seminars in cell biology,
Shohko Tsunawaki, and Lucia S Yoshida, and Satoshi Nishida, and Toshihiro Kobayashi, and Takashi Shimoyama
April 1996, The Journal of experimental medicine,
Shohko Tsunawaki, and Lucia S Yoshida, and Satoshi Nishida, and Toshihiro Kobayashi, and Takashi Shimoyama
August 1988, Immunology and cell biology,
Shohko Tsunawaki, and Lucia S Yoshida, and Satoshi Nishida, and Toshihiro Kobayashi, and Takashi Shimoyama
April 1991, The Journal of biological chemistry,
Shohko Tsunawaki, and Lucia S Yoshida, and Satoshi Nishida, and Toshihiro Kobayashi, and Takashi Shimoyama
June 1990, The Journal of infectious diseases,
Shohko Tsunawaki, and Lucia S Yoshida, and Satoshi Nishida, and Toshihiro Kobayashi, and Takashi Shimoyama
April 1995, Journal of immunology (Baltimore, Md. : 1950),
Shohko Tsunawaki, and Lucia S Yoshida, and Satoshi Nishida, and Toshihiro Kobayashi, and Takashi Shimoyama
June 2004, Hypertension (Dallas, Tex. : 1979),
Shohko Tsunawaki, and Lucia S Yoshida, and Satoshi Nishida, and Toshihiro Kobayashi, and Takashi Shimoyama
June 2003, Journal of pediatric surgery,
Shohko Tsunawaki, and Lucia S Yoshida, and Satoshi Nishida, and Toshihiro Kobayashi, and Takashi Shimoyama
January 1992, Advances in enzymology and related areas of molecular biology,
Shohko Tsunawaki, and Lucia S Yoshida, and Satoshi Nishida, and Toshihiro Kobayashi, and Takashi Shimoyama
June 1988, Hematology/oncology clinics of North America,
Copied contents to your clipboard!